This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Coronary Stenosis
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The objective of this clinical trial is to study the early safety and feasibility of the Shockwave Coronary Lithoplasty System. To demonstrate that the Shockwave device can safely and effectively deliver localized shockwave energy for balloon dilatation of calcified, stenotic, de novo coronary lesions.

Provided treatments

  • Device: Shockwave Coronary Lithoplasty System
Tris trial is registered with FDA with number: NCT02758379. The sponsor of the trial is Shockwave Medical, Inc. and it is looking for 12 volunteers for the current phase.
Official trial title:
Early Safety and Feasibility Study of the Shockwave Coronary Lithoplasty™ System in Coronary Arteries